Tulodiv, 600 , 50 , 300 , 600 mg, 50 mg, 300 mg, FC tablets
PDF Leaflet Revision Date: 17 June 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of HIV infection in adults and adolescents from 18 years.
Dosage (summary)
One tablet once daily for adults and adolescents >40 kg.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Contraindicated in first trimester; use caution in later trimesters; not recommended during breastfeeding.
Key Drug Interactions
- Metformin contraindicated
- Avoid with dofetilide and pilsicainide
- Caution with antacids containing polyvalent cations
Contraindications
- Hypersensitivity to components
- Moderate/severe hepatic impairment
- Creatinine clearance < 50 ml/min
Common side effects
- Hypersensitivity reactions
- Nausea
- Diarrhea
- Fatigue
- Rash
Counselling Points
- Inform about hypersensitivity risks
- Do not restart after hypersensitivity reaction
- Regular monitoring of viral load and CD4 counts
Serious warnings
- Risk of hypersensitivity reactions
- Potential for lactic acidosis
- Increased risk of myocardial infarction
Important Disclaimer
The Tulodiv, 600 , 50 , 300 , 600 mg, 50 mg, 300 mg, FC tablets professional information leaflet below is the property of Adcock Ingram and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
